🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to investigate the possibility that a...
Status
Completed
Location
Southern CA Center for Sexual Health and Survivorship Medicine
Start Date
2018-07-09
Trial ID
NCT03592121
AB-101 is an off-the shelf, allogeneic cell product made of "natural killer...
Status
Completed
Location
Artiva Clinical Trial Site
Start Date
2021-03-29
Trial ID
NCT04673617
Treatments Being Tested
A Phase 2b study investigating the efficacy of zabalafin in people with mil...
Status
Recruiting
Location
Canopy Clinical Northern Beaches
Start Date
2025-03-25
Trial ID
NCT06855745
Treatments Being Tested
This three-part, Phase 1 protocol will be the first clinical study of AB-10...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2023-08-30
Trial ID
NCT05960240
Treatments Being Tested
AB-101 (also known as AlloNK) is an off-the shelf, allogeneic cell product ...
Status
Active Not Recruiting
Location
Artiva Investigational Site Birmingham
Start Date
2024-04-03
Trial ID
NCT06265220
Treatments Being Tested
This study will evaluate the safety and activity of AB-101 in combination w...
Status
Recruiting
Location
IRIS Research and Development, LLC
Start Date
2024-05-15
Trial ID
NCT06581562
Treatments Being Tested
AFM13-203 is a phase 2, open-label, multi-center, multi-cohort study with a...
Status
Terminated
Location
O'Neal Comprehensive Cancer Center at UAB
Start Date
2023-10-10
Trial ID
NCT05883449
Treatments Being Tested